Table of Contents Table of Contents
Previous Page  1609 / 1851 Next Page
Information
Show Menu
Previous Page 1609 / 1851 Next Page
Page Background

Systemic treatment

Indication – extrapolate from histology (breast adenoCa)

N+, LVSI+ - in breast Ca, would offer systemic treatment

What systemic treatment?

Consider therapeutic indices AND economic cost

ER positive - give tamoxifen (benefit U/K, toxicity low,

cost low)

HER-2 positive – do not give Herceptin (benefit U/K,

toxicity high, cost very high)

Chemo - ??? (benefit U/K, toxicity high, cost high)